ProPhase Labs, Inc. Share Price & Technical Analysis
PRPH · $0.11 (+22.22%)
Healthcare / Diagnostics & Research
$0.11
+22.22%
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart E…
Price chart
Seasonality
May has 4 positive and 0 negative years (last 5 years shown)
0% return in May, 15% avg return in past 3 year May month.
-110% return in 2026, -97% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -60% | 0% | -50% | 0% | 0% | – | – | – | – | – | – | – | -110% |
| 25 | -67% | 67% | -7% | -10% | 9% | 5% | -5% | -3% | 39% | -20% | -42% | -82% | -116% |
| 24 | 8% | -8% | 43% | -30% | 12% | -19% | -26% | -15% | -11% | -6% | -66% | 0% | -119% |
| 23 | -14% | -11% | 7% | -5% | 24% | -25% | 0% | -41% | 2% | 0% | 15% | -10% | -57% |
| 22 | 4% | -12% | 11% | 2% | 23% | 38% | -19% | 16% | -6% | 5% | -14% | -7% | 42% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics testing technologies to analyze entire genomes, including the genes and chromosomes in deoxyribonucleic acid; DNA Expand, a platform that allows consumers to upload their DNA data from previous DNA tests obtained from other service providers; and LB-1 and LB-2 for the treatment of cancer, inflammatory diseases or symptoms and memory related syndromes, diseases or symptoms, including dementia and Alzheimer's disease. In addition, the company provides a broad range of COVID-19 related clinical diagnostic and testing services, comprising PCR testing for COVID-19, and Influenza A and B, as well as rapid antigen testing for COVID-19. It offers its genome sequencing products to consumers online with plans to sell in food, drug, and mass retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$580.28K
P/E ratio
—
52W high
$6.70
52W low
$0.07
Volume
7
Beta
0.17
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is ProPhase Labs, Inc. share price today?
- ProPhase Labs, Inc. (PRPH) last traded around $0.11 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does PRPH have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for PRPH. Download the app for real-time alerts.
- How can I analyze ProPhase Labs, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.